Travere Therapeutics (TVTX) PT Raised to $56 at Guggenheim

April 24, 2026 6:40 AM

(Updated - April 24, 2026 6:45 AM EDT)

Guggenheim analyst Vamil Divan raised the price target on Travere Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found